Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc

Bullboard Posts

Post by anythingon Dec 19, 2012 6:28pm

221 Views

Post# 20752906

market cap

i see a market cap of 5million quoted well at 1cent it is now 1,455,000 with tax pools of 60million allons is definately worth the 3 or even 5cents quoted on this board with total liabilities at only 1,560,000.

its a fire sale.

Chris

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario